AI주식인사이트AI Stock Insight
C

녹십자엠에스

142280KOSDAQ의료용품 및 기타 의약 관련제품 제조업

43.5 / 100

Reference Date: 2026-07-24

Financial Score17.0 / 40
News Sentiment12.5 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk. Declined 10.0% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Lotte MSD primarily operates in diagnostic reagents (54.1%), blood glucose management (14.4%), and hemodialysis solutions (31.1%), focusing on the development and sales of medical devices and diagnostic products. The company is advancing the development of multi-diagnostic platforms using AI and genomic analysis in the diagnostic reagents sector, while expanding its hemodialysis solution market through collaborations with global firms.

Number of Employees

131people

Average Salary

47.0M KRW

Score Calculation Basis

Detailed Financial Score

PER
16.04Industry Average 15.183.0Point

Higher than industry avg (caution)

PBR
1.40Industry Average 1.092.5Point

Higher than industry avg (caution)

ROE
7.71Industry Average -4.893.5Point

Well below industry avg

Debt Ratio
18.88Industry Average 6.860.0Point

2.8x industry avg (risky)

Trend 2023~20258.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲7.4% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲26.7% (2-year basis)

ROE Trend
3.0 / 4

Avg ROE 7.1% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (3%, downtrend)

Current 2,710Won52-week high 6,23052-week low 2,565
1-month return1.0Point

1m -9.97% (falling)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0
  • Neutral신주인수권행사가액의조정2026-07-20
  • Neutral주식등의대량보유상황보고서(일반)2026-07-01
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-30
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-30